Order Article Reprints

Koehler VF, Adam P, Fuss CT, Jiang L, Berg E, Frank-Raue K, Raue F, Hoster E, Knösel T, Schildhaus H-U, et al. Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis. Cancers. 2022; 14(14):3405. https://doi.org/10.3390/cancers14143405

Koehler, Viktoria Florentine, Pia Adam, Carmina Teresa Fuss, Linmiao Jiang, Elke Berg, Karin Frank-Raue, Friedhelm Raue, Eva Hoster, Thomas Knösel, Hans-Ulrich Schildhaus, and et al. 2022. "Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis" Cancers 14, no. 14: 3405. https://doi.org/10.3390/cancers14143405

Koehler, V. F., Adam, P., Fuss, C. T., Jiang, L., Berg, E., Frank-Raue, K., Raue, F., Hoster, E., Knösel, T., Schildhaus, H.-U., Negele, T., Siebolts, U., Lorenz, K., Allelein, S., Schott, M., Spitzweg, C., & Kroiss, M., on behalf of the German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid Glands. (2022). Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis. Cancers, 14(14), 3405. https://doi.org/10.3390/cancers14143405